Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 7:20 p.m.

    📋 ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 17:25:00

    Event Type: Financial Results

    Event Details:

    Arcutis Biotherapeutics (ARQT) Reports Q3 2022 Financial Results Arcutis Biotherapeutics (ARQT) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 61512
      • anticipated by the end of 2022
      • expected in 2023

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 12.02K 14.17K $-2.15K -15.16%
    Current Assets Property Equipment Net 2.08K 2.26K $-183.00 -8.09%
    Current Assets Operating Lease Right Of Use Assets 2.88K 3.04K $-158.00 -5.20%
    Current Assets Other Assets 78.00 78.00 $0.00 +0.00%
    Current Liabilities Accounts Payable 8.44K 8.44K $0.00 +0.00%
    Current Liabilities Accrued Liabilities 18.46K 25.54K $-7.08K -27.71%
    Current Liabilities Operating Lease Liabilities 582.00 433.00 $149.00 +34.41%
    Current Liabilities Other Long Term Liabilities 12.00 25.00 $-13.00 -52.00%
    Operating Expenses Loss From Operations -42.08K -128.46K $86.38K +67.24%
    Other Income Expense Other Income Net 72.00 563.00 $-491.00 -87.21%
    Other Income Expense Interest Expense -3.84K -3.84K $0.00 +0.00%
    Other Income Expense Total Other Income Expense 72.00 -3.27K $3.35K +102.20%
    Net Loss -42.01K -42.01K $0.00 +0.00%
    Per Share Information Net Loss Per Share -0.84 -0.84 $0.00 +0.00%
    Per Share Information Weighted Average Shares 50.00M 50.97M $-969.75K -1.90%
    Prepaid Expenses and Other Current Assets 14.17K 14.17K $0.00 +0.00%
    Property and Equipment, Net 2.26K 2.26K $0.00 +0.00%
    Other Assets 78.00 78.00 $0.00 +0.00%
    Accounts Payable 7.35K 7.35K $0.00 +0.00%
    Accrued Liabilities 25.54K 25.54K $0.00 +0.00%
    Loss from Operations -42.08K -128.46K $86.38K +67.24%
    Other Income, Net 72.00 563.00 $-491.00 -87.21%
    Interest Expense -3.84K -3.84K $0.00 +0.00%
    Net Loss -42.01K -42.01K $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Arcutis Biotherapeutics
    • CIK: 0001787306
    • Ticker Symbol: ARQT
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories